Omada Health shares jumped more than 40% in their Nasdaq debut Friday after the virtual chronic care company priced its stock at $19 per share in its IPO. The stock opened at $23 and quickly traded past $27. The company said in a press release late Thursday that it sold 7.9 million shares in the … Read more
Biopharmaceutical stocks’ underperformance versus the broader market for a third-straight year is an opportunity for investors, according to JPMorgan. Analyst Chris Schott said in the firm’s June outlook for biopharma that the sector’s poor performance can be traced back to concerns over President Donald Trump’s tariffs and his ” most favored nation ” executive order. … Read more
Omada Health virtual health program. Courtesy: Omada Health Omada Health priced its IPO at $19 per share on Thursday, in the middle of the expected range. The virtual chronic care company said in a press release that 7.9 million shares are being sold in the offering, amounting to $150 million. Omada, founded in 2012, will … Read more
During their last year of completing work for doctoral degrees in physiology, twin sisters Michal Mor and Merav Mor started to compete in Ironman triathlon races. The demand for peak fitness led them to the realize the importance of understanding personal metabolism, and the lack of data being collected on it through devices accessible to … Read more
Two graduate students research chemical products in a laboratory in Xiwangzhuang Town, Zaozhuang City, Shandong province of China, on Dec. 26, 2023. Nurphoto | Nurphoto | Getty Images BEIJING — For all the attention on U.S.-China competition in artificial intelligence, new studies point to China’s rapid rise in biotechnology, especially for drug and agricultural development. … Read more
Attendees walk through the lobby at the American Society of Clinical Oncology annual meeting in Chicago. Tim Boyle | Bloomberg | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. I’m back in New … Read more
The Hims logo arranged on a smartphone in New York, US, on Wednesday, Feb. 12, 2025. Bloomberg | Bloomberg | Getty Images Hims & Hers Health announced Tuesday it will acquire European telehealth platform Zava in its push to expand globally. “We’re excited to take this moment to really accelerate both the European expansion, but … Read more
Jonathan Raa | Nurphoto | Getty Images Elon Musk’s brain tech startup Neuralink has closed a $650 million funding round, the company announced Monday. ARK Invest, Founders Fund, Sequoia Capital, Thrive Capital, Lightspeed Venture Partners and other firms participated in the round, according to a press release. Neuralink said the fresh capital will help the … Read more
Dr. Matthew Willsey working in the operating room. Courtesy of the University of Michigan Neurotech startup Paradromics on Monday announced it has implanted its brain-computer interface in a human for the first time. The procedure took place May 14 at the University of Michigan with a patient who was already undergoing neurosurgery to treat epilepsy. … Read more
Speaker Mike Johnson, R-La., on Sunday defended cuts to Medicaid in the budget bill House Republicans passed last month from allegations that millions of Americans could lose their access to the program, saying that “4.8 million people will not lose their Medicaid unless they choose to do so.” Johnson told NBC News’ “Meet the Press” that the … Read more